Trials / Conditions / CNS Disease
CNS Disease
5 registered clinical trials studyying CNS Disease.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cance NCT04512261 | Reva Basho | Phase 1 / Phase 2 |
| Unknown | Determination of COVID-19 Related Virus in Central Nervous System NCT04775784 | IRCCS San Raffaele | — |
| Completed | Blood-Brain Barrier Penetration of Therapeutic Agents in Human NCT04571996 | Orion Corporation, Orion Pharma | Phase 1 |
| Terminated | Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma NCT00895960 | M.D. Anderson Cancer Center | Phase 1 |
| Terminated | ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases NCT00496379 | Nancy Lin, MD | Phase 2 |